JVMSX
Price
$31.13
Change
+$0.02 (+0.06%)
Updated
Jul 31 closing price
Net Assets
23.61B
VVMCX
Price
$17.80
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
701.4M
Interact to see
Advertisement

JVMSX vs VVMCX

JVMSX vs VVMCX Comparison Chart in %
View a ticker or compare two or three
VS
JVMSX vs. VVMCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMSX is a Hold and VVMCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.6B vs. VVMCX (701M). VVMCX pays higher dividends than JVMSX: VVMCX (1.07) vs JVMSX (0.34). JVMSX was incepted earlier than VVMCX: JVMSX (14 years) vs VVMCX (28 years). JVMSX (1.25) is less costly to investors than VVMCX (0.83). VVMCX is a more actively managed with annual turnover of: 141.00 vs. JVMSX (48.00). JVMSX (0) and VVMCX (0) have matching initial minimum investment requirements. JVMSX annual gain was more profitable for investors over the last year : 8.28 vs. VVMCX (5.72). JVMSX return over 5 years is better than : 13.82 vs. VVMCX (-14.60).
JVMSXVVMCXJVMSX / VVMCX
Total Expense Ratio1.240.83149%
Annual Report Gross Expense Ratio1.250.83151%
Fund Existence14 years28 years-
Gain YTD13.9881.890740%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B701M3,367%
Annual Yield % from dividends0.341.0732%
Returns for 1 year8.285.72145%
Returns for 3 years17.351.291,345%
Returns for 5 years13.82-14.60-95%
Returns for 10 years57.71-3.81-1,514%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLWFX85.060.68
+0.81%
Columbia Cornerstone Growth Inst 2
PCLCX15.900.08
+0.51%
PACE Large Co Growth Equity P
WCMSX25.380.04
+0.16%
WCM International Small Cap Growth Instl
DIFFX12.90-0.03
-0.23%
MFS Diversified Income R3
SHPCX14.93-0.17
-1.13%
Saratoga Health & Biotechnology C